TY - JOUR
T1 - A Collaborative Evaluation of LC-MS/MS Based Methods for BMAA Analysis: Soluble Bound BMAA Found to Be an Important Fraction
AU - Faassen, Els
AU - Antoniou, Maria G.
AU - Beekman-Lukassen, Wendy
AU - Blahova, Lucie
AU - Chernova, Ekaterina
AU - Christophoridis, Christophoros
AU - Combes, Audrey
AU - Edwards, Christine
AU - Fastner, Jutta
AU - Harmsen, Joop
AU - Hiskia, Anastasia
AU - Ilag, Leopold L.
AU - Kaloudis, Triantafyllos
AU - Lopicic, Srdjan
AU - Lürling, Miquel
AU - Mazur-Marzec, Hanna
AU - Meriluoto, Jussi
AU - Porojan, Cristina
AU - Viner-Mozzini, Yehudit
AU - Zguna, Nadezda
N1 - 6085, AqE; Data archiving: Property of WUR
PY - 2016/3
Y1 - 2016/3
N2 - Exposure to beta-N-methylamino-l-alanine (BMAA) might be linked to the incidence of amyotrophic lateral sclerosis, Alzheimer's disease and Parkinson's disease. Analytical chemistry plays a crucial role in determining human BMAA exposure and the associated health risk, but the performance of various analytical methods currently employed is rarely compared. A CYANOCOST initiated workshop was organized aimed at training scientists in BMAA analysis, creating mutual understanding and paving the way towards interlaboratory comparison exercises. During this workshop, we tested different methods (extraction followed by derivatization and liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS) analysis, or directly followed by LC-MS/MS analysis) for trueness and intermediate precision. We adapted three workup methods for the underivatized analysis of animal, brain and cyanobacterial samples. Based on recovery of the internal standard D(3)BMAA, the underivatized methods were accurate (mean recovery 80%) and precise (mean relative standard deviation 10%), except for the cyanobacterium Leptolyngbya. However, total BMAA concentrations in the positive controls (cycad seeds) showed higher variation (relative standard deviation 21%-32%), implying that D(3)BMAA was not a good indicator for the release of BMAA from bound forms. Significant losses occurred during workup for the derivatized method, resulting in low recovery (<10%). Most BMAA was found in a trichloroacetic acid soluble, bound form and we recommend including this fraction during analysis.
AB - Exposure to beta-N-methylamino-l-alanine (BMAA) might be linked to the incidence of amyotrophic lateral sclerosis, Alzheimer's disease and Parkinson's disease. Analytical chemistry plays a crucial role in determining human BMAA exposure and the associated health risk, but the performance of various analytical methods currently employed is rarely compared. A CYANOCOST initiated workshop was organized aimed at training scientists in BMAA analysis, creating mutual understanding and paving the way towards interlaboratory comparison exercises. During this workshop, we tested different methods (extraction followed by derivatization and liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS) analysis, or directly followed by LC-MS/MS analysis) for trueness and intermediate precision. We adapted three workup methods for the underivatized analysis of animal, brain and cyanobacterial samples. Based on recovery of the internal standard D(3)BMAA, the underivatized methods were accurate (mean recovery 80%) and precise (mean relative standard deviation 10%), except for the cyanobacterium Leptolyngbya. However, total BMAA concentrations in the positive controls (cycad seeds) showed higher variation (relative standard deviation 21%-32%), implying that D(3)BMAA was not a good indicator for the release of BMAA from bound forms. Significant losses occurred during workup for the derivatized method, resulting in low recovery (<10%). Most BMAA was found in a trichloroacetic acid soluble, bound form and we recommend including this fraction during analysis.
KW - 6-aminoquinolyl-N-hydroxysuccinimidyl carbamate (AQC)
KW - seafood
KW - phytoplankton
KW - Daphnia magna
KW - Liquid chromatography-tandem mass spectrometry (LC-MS/MS)
KW - beta-N-methylamino-l-alanine (BMAA)
KW - Internal standard
KW - hydrophilic interaction liquid chromatography (HILIC)
KW - cycad
KW - N-(2-aminoethyl) glycine (AEG)
KW - alpha,gamma-diaminobutyric acid (DAB)
KW - international
U2 - 10.3390/md14030045
DO - 10.3390/md14030045
M3 - Article
SN - 1660-3397
VL - 14
JO - Marine Drugs
JF - Marine Drugs
IS - 3
ER -